These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7911406

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

  • 4. [Efficiency and tolerance of terazosine in ambulatory patients with benign prostatic hypertrophy: comparative randomized and double-blind trial versus alfuzosin. The MG Terazosine Group].
    Fourcade RO.
    Prog Urol; 2000 Apr; 10(2):246-53. PubMed ID: 10857142
    [Abstract] [Full Text] [Related]

  • 5. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
    Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN.
    Urology; 2004 Nov; 64(5):881-6. PubMed ID: 15533470
    [Abstract] [Full Text] [Related]

  • 6. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
    Ciuffetti G, Mercuri M, Lombardini R, Palazzetti D, Rizzo MT, Parnetti L.
    Minerva Med; 1989 Nov 12; 80(11):1237-40. PubMed ID: 2689916
    [Abstract] [Full Text] [Related]

  • 9. [Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
    Lombardini R, Ciuffetti G, Paltriccia R, Scarponi AM, Savastano V, Palazzetti D, Mercuri M, Parnetti L.
    Ric Clin Lab; 1989 Nov 12; 19 Suppl 1():117-9. PubMed ID: 2629069
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical efficacy and safety of terazosine (setegis) in patients with benign prostatic hyperplasia with concomitant cardiovascular diseases].
    Trapeznikova MF, Gurevich MA, Pozdniakov KV, Tazina SIa, Bychkova NV.
    Urologiia; 2005 Nov 12; (2):50-3. PubMed ID: 15989029
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 12; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN.
    J Urol; 2003 Feb 12; 169(2):592-6. PubMed ID: 12544314
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.